Sangamo Biosciences (SGMO) Files $100M Mixed Shelf
Tweet Send to a FriendGet Alerts SGMO Hot Sheet
Up)
Trade SGMO Now!
Sangamo Biosciences, Inc. (Nasdaq: SGMO), filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $100 million of Common Stock, Preferred Stock, Debt Securities, Warrants, or any combination thereof.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases
- Cimatron (CIMT) Secondary Offering Priced at $6.25/Share
- TCP Capital (TCPC) Prices Upsized 4.5M Common Stock Offering
Create E-mail Alert Related Categories
Equity Offerings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
